Casein phosphopeptide amorphous calcium fluoride phosphate
酪蛋白磷酸肽无定形氟化钙磷酸盐
Report date: 2022/07/04 19:38:02
NME
Base Information
Drug NameCasein phosphopeptide amorphous calcium fluoride phosphate
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesPlovdiv Medical University
China Registration ClassN/A
Develop Information
Active CompaniesPlovdiv Medical UniversitySuez Canal University
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A